These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 529021)

  • 1. Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination.
    Chiou WL
    J Pharmacokinet Biopharm; 1979 Oct; 7(5):527-36. PubMed ID: 529021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics (second of two parts).
    Greenblatt DJ; Koch-Weser J
    N Engl J Med; 1975 Nov; 293(19):964-70. PubMed ID: 1101062
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug metabolite kinetics.
    Houston JB
    Pharmacol Ther; 1981; 15(3):521-52. PubMed ID: 7048351
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug distribution and binding.
    Oie S
    J Clin Pharmacol; 1986; 26(8):583-6. PubMed ID: 3793947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic pitfalls in the estimation of the breast milk/plasma ratio for drugs.
    Wilson JT; Brown RD; Hinson JL; Dailey JW
    Annu Rev Pharmacol Toxicol; 1985; 25():667-89. PubMed ID: 3890712
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
    Tillement JP; Duché JC; Barré J
    Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonlinear physiologic pharmacokinetic model: I. Steady-state.
    Wagner JG; Szpunar GJ; Ferry JJ
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):73-92. PubMed ID: 4020623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.
    Vaughan
    Eur J Clin Pharmacol; 1977; 11(1):57-64. PubMed ID: 832659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics.
    Gillespie WR; Veng-Pedersen P
    J Pharmacokinet Biopharm; 1985 Aug; 13(4):441-51. PubMed ID: 4087171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of drug terminal half-life and terminal volume of distribution after intravenous dosing based on drug clearance, steady-state volume of distribution, and physiological parameters of the body.
    Berezhkovskiy LM
    J Pharm Sci; 2013 Feb; 102(2):761-71. PubMed ID: 23233148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of lungs to total body clearance: linear and nonlinear effects.
    Collins JM; Dedrick RL
    J Pharm Sci; 1982 Jan; 71(1):66-70. PubMed ID: 7057383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classical pharmacokinetics to the frontier.
    Garrett ER
    J Pharmacokinet Biopharm; 1973 Oct; 1(5):341-61. PubMed ID: 4787616
    [No Abstract]   [Full Text] [Related]  

  • 14. Pitfalls of pharmacokinetic dosage guidelines in renal insufficiency.
    Turnheim K
    Eur J Clin Pharmacol; 1991; 40(1):87-93. PubMed ID: 2060552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic model-independent approach for estimating dose required to give desired steady-state trough concentrations of drug in plasma.
    Slattery JT
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):105-10. PubMed ID: 7381689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics in clinical practice. I. Concepts.
    Gibaldi M; Levy G
    JAMA; 1976 Apr; 235(17):1864-7. PubMed ID: 946488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
    Ye M; Nagar S; Korzekwa K
    Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
    Keller F; Maiga M; Neumayer HH; Lode H; Distler A
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized solution to linear, to-compartment, open model for drug distribution.
    Bischoff KB; Dedrick RL
    J Theor Biol; 1970 Oct; 29(1):63-8. PubMed ID: 5493292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.